Skip to main content
Viewing from:
Department GEZ-LTA Erasmushogeschool
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Archive
Search for this keyword
Advanced search
Close
More
Main menu
Archive
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are viewing from:
Department GEZ-LTA Erasmushogeschool
You are here
Home
Archive
Volume 70, Issue 8
Corrections
Email alerts
Share
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
See original article:
Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies - February 01, 2009
Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis - January 01, 2009
Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade - June 01, 2009
Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study - July 01, 2009
Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe - April 01, 2009
Long-term efficacy and toxicity of ciclosporin A in combination with methotrexate in poor prognosis rheumatoid arthritis - May 01, 2009
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal - June 01, 2009
Diagnosing axial spondyloarthropathy. The new Assessment in SpondyloArthritis international Society criteria: MRI entering centre stage - June 01, 2009
Baseline and 1-year magnetic resonance imaging of the sacroiliac joint and lumbar spine in very early inflammatory back pain. Relationship between symptoms, HLA-B27 and disease extent and persistence - November 01, 2009
Adaptation and cross-cultural validation of the rheumatoid arthritis work instability scale (RA–WIS) - November 01, 2009
MRI and clinical findings in patients with ankylosing spondylitis eligible for anti-tumour necrosis factor therapy after a short course of etoricoxib - September 01, 2009
Bone loss in patients with active early rheumatoid arthritis: infliximab and methotrexate compared with methotrexate treatment alone. Explorative analysis from a 12-month randomised, double-blind, placebo-controlled study - December 01, 2009
Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients - December 01, 2009
Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: the COMET trial - January 01, 2010
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009 - January 01, 2010
A diagnostic algorithm for persistence of very early inflammatory arthritis: the utility of power Doppler ultrasound when added to conventional assessment tools - February 01, 2010
Mesenchymal stem cells in rheumatoid synovium: enumeration and functional assessment in relation to synovial inflammation level - February 01, 2010
Efficacy and safety of pamapimod in patients with active rheumatoid arthritis receiving stable methotrexate therapy - February 01, 2010
The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis - March 01, 2010
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search - April 01, 2010
Treating rheumatoid arthritis to target: recommendations of an international task force - April 01, 2010
PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population - April 01, 2010
Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial) - March 01, 2010
The fatty Romanus lesion: a non-inflammatory spinal MRI lesion specific for axial spondyloarthropathy - May 01, 2010
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs - June 01, 2010
Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment - June 01, 2010
Dissection of the FCGR3A association with RA: increased association in men and with autoantibody positive disease - June 01, 2010
Continued inhibition of structural damage over 2 years in patients with rheumatoid arthritis treated with rituximab in combination with methotrexate - June 01, 2010
Bone loss in very early inflammatory back pain in undifferentiated spondyloarthropathy: a 1-year observational study - July 01, 2010
Follow-up standards and treatment targets in rheumatoid arthritis: results of a questionnaire at the EULAR 2008 - March 01, 2010
No evidence for association of the KLF12 gene with rheumatoid arthritis in a large UK cohort - July 01, 2010
Confirmation of association of the REL locus with rheumatoid arthritis susceptibility in the UK population - August 01, 2010
Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study - May 01, 2010
Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped? - September 01, 2010
Double-blind placebo-controlled trial of etanercept in the prevention of work disability in ankylosing spondylitis - November 01, 2010
Beneficial effect of 1-year etanercept treatment on the lipid profile in responding patients with rheumatoid arthritis: the ETRA study - November 01, 2010
Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register - June 01, 2010
The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus - February 01, 2009
Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA - June 01, 2010
PDF
Miscellaneous
Corrections
Corrections
Free
Share this article
Click the icon of the social media platform on which you would like to share this article.
Share This Article:
Copy
Email this article to a friend
We will not keep your email address; we ask for it so your friend knows the email isn't spam.
Your email:
*
Your name:
*
Send to:
*
Enter multiple addresses on separate lines or separate them with commas.
You are going to email the following
Corrections
Message subject:
(
Your Name
) has forwarded a page to you from Annals of the Rheumatic Diseases
Message body:
(
Your Name
) thought you would like to see this page from the Annals of the Rheumatic Diseases web site.
Your personal message:
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Read the full text or download the PDF:
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF
